(Q46428527)

22 December 2017

title

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials (English)

1 reference

22 December 2017

0 references

1

1 reference

22 December 2017

Wim Oyen

2

object named as

Wim J G Oyen

0 references

author name string

Wim J G Oyen

2

1 reference

22 December 2017

Corneline J Hoekstra

3

1 reference

22 December 2017

Otto S Hoekstra

4

1 reference

22 December 2017

Eric P Visser

5

1 reference

22 December 2017

Antoon T Willemsen

6

1 reference

22 December 2017

Bertjan Arends

7

1 reference

22 December 2017

Fred J Verzijlbergen

8

1 reference

22 December 2017

Josee Zijlstra

9

1 reference

22 December 2017

Anne M Paans

10

1 reference

22 December 2017

Emile F I Comans

11

1 reference

22 December 2017

Jan Pruim

12

1 reference

22 December 2017

publication date

15 August 2008

1 reference

22 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

22 December 2017

volume

35

1 reference

22 December 2017

issue

12

1 reference

22 December 2017

page(s)

2320-2333

1 reference

22 December 2017

Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0874-2

CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0874-2

Defining a radiotherapy target with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0874-2

Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0874-2

CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0874-2

Application of oral contrast media in coregistered positron emission tomography-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0874-2

Clinical experience with a commercially available negative oral contrast medium in PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0874-2

PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients

21 January 2018

1 reference

12 December 2020

Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.

1 reference

12 December 2020

Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study

1 reference

12 December 2020

Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.

1 reference

12 December 2020

Correction of oral contrast artifacts in CT-based attenuation correction of PET images using an automated segmentation algorithm.

1 reference

12 December 2020

Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer

1 reference

12 December 2020

Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.

1 reference

12 December 2020

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

12 December 2020

Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?

1 reference

12 December 2020

Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.

1 reference

12 December 2020

Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

1 reference

12 December 2020

Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.

1 reference

12 December 2020

The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis

1 reference

12 December 2020

The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology

1 reference

12 December 2020

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations

1 reference

12 December 2020

Use of PET for monitoring cancer therapy and for predicting outcome

1 reference

12 December 2020

Oral contrast medium in PET/CT: should you or shouldn't you?

1 reference

12 December 2020

18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology.

1 reference

12 December 2020

Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies

1 reference

12 December 2020

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

12 December 2020

Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial

1 reference

12 December 2020

Initial experience with oral contrast in PET/CT: phantom and clinical studies.

1 reference

12 December 2020

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

12 December 2020

FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study.

1 reference

12 December 2020

Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding

1 reference

12 December 2020

Cancer of unknown primary.

1 reference

12 December 2020

Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation

1 reference

12 December 2020

Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging

1 reference

12 December 2020

A novel iterative method for lesion delineation and volumetric quantification with FDG PET.

1 reference

12 December 2020

Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.

1 reference

12 December 2020

Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?

1 reference

12 December 2020

Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values

1 reference

12 December 2020

Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.

1 reference

12 December 2020

Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods

1 reference

12 December 2020

Recommendations on the use of 18F-FDG PET in oncology

1 reference

12 December 2020

Positron emission tomography as an imaging biomarker

1 reference

12 December 2020

Understanding the standardized uptake value, its methods, and implications for usage.

1 reference

12 December 2020

10.1007/S00259-008-0874-2

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017